Study proposes reconsidering how histone deacetylase inhibitors work in cancer treatment
The authors propose that HDAC inhibitors may also interfere with other proteins and that targeting such proteins may suppress cancer.
Read More
The authors propose that HDAC inhibitors may also interfere with other proteins and that targeting such proteins may suppress cancer.
Read MoreA novel way the immune system attacks target cells reshapes long-held assumptions in immunology and shows direct implications for the field of cancer immunology and bone marrow transplantation.
Read MoreThe Baylor team is building the case for SRC-3 as a promising therapeutic target for next-generation cancer immunotherapy.
Read MoreThis novel immunotherapy may help the immune system recognize and attack cancer cells in a way that other immunotherapies have not been able to do thus far.
Read MoreThe study lays a foundation for designing CAR molecules that maximize antitumor activity beyond B cell malignancies.
Read MoreResearchers relate their journey to finding a promising method to address CAR T cell challenges in treating solid tumors.
Read MoreThe team integrated proteogenomic datasets of more than 1,000 tissue samples spanning 10 cancer types to illuminate protein targets for cancer therapy.
Read MoreDetailed molecular characterization of endometrial carcinomas identifies potential markers for guiding more precise treatment.
Read MoreThe findings in animal models warrant continuing investigations to develop a novel, more effective and longer-lasting cancer therapy.
Read MoreA Baylor College of Medicine-Rice University collaboration is making strides in the treatment of mesothelioma and other cancers.
Read More